-
Taxonomy & unit
-
ratio: %
-
Description
-
The operating margin measures the profit a company makes on a dollar of sales after accounting for the direct costs involved in earning those revenues.
-
Summary
-
Lineage Cell Therapeutics, Inc. quarterly/annual Operating Margin history and growth rate from Q4 2020 to Q4 2024.
- Lineage Cell Therapeutics, Inc. Operating Margin for the quarter ending December 31, 2024 was -226 %, a 18.2% increase year-over-year.
- Lineage Cell Therapeutics, Inc. annual Operating Margin for 2024 was -226 %, a 18.2% increase from 2023.
- Lineage Cell Therapeutics, Inc. annual Operating Margin for 2023 was -277 %, a 80.5% decline from 2022.
- Lineage Cell Therapeutics, Inc. annual Operating Margin for 2022 was -153 %, a 86.5% increase from 2021.
Operating Margin, Quarterly (%)
Operating Margin, YoY Quarterly Growth (%)